Electrochemical and Surface-Plasmon Correlation of a Serum-Autoantibody Immunoassay with Binding Insights: Graphenyl Surface versus Mercapto-Monolayer Surface

Analytical Chemistry
Gayan PremaratneSadagopan Krishnan

Abstract

We present here the correlation of picomolar affinities between surface-plasmon and electrochemical immunoassays for the binding of serum glutamic acid decarboxylase 65 autoantibody (GADA), a biomarker of type 1 diabetes (T1D), to its antigen GAD-65. Carboxylated (∼5.0%)-graphene-modified immunoassembly on a gold surface-plasmon chip or on an electrochemical array provided significantly larger binding affinity, higher sensitivity, and lower detection limits than a self-assembled monolayer surface of mercaptopropionic acid (MPA). Estimation of the relative surface -COOH groups by covalent tagging of an electroactive aminoferrocene showed that the graphenyl surface displayed a greater number of -COOH groups (9-fold) than the MPA surface. X-ray-photoelectron-spectroscopy analysis showed more C-O and C═O functionalities on the graphene-COOH surface than on the MPA surface. The graphene-COOH coating on gold exhibited ∼5.5-fold enhancement of plasmon signals compared with a similar coating on a plain glass surface. In summary, this article provides a quantitative comparison of carboxylated graphene with a mercapto-monolayer immunoassembly. Additionally, we propose that the binding-constant value can be useful as a quality-control che...Continue Reading

References

Jul 31, 2001·Lancet·M A Atkinson, G S Eisenbarth
Jul 13, 2002·American Journal of Medical Genetics·Hans K AkerblomMikael Knip
May 19, 2005·Journal of the American Chemical Society·Sang Jun SonSang Bok Lee
Nov 25, 2005·Diabetes·Catherine PihokerAke Lernmark
Jun 29, 2006·Journal of the American Chemical Society·Savka I StoevaChad A Mirkin
Aug 8, 2006·Autoimmunity Reviews·Clive H Wasserfall, Mark A Atkinson
Oct 21, 2009·Proceedings of the National Academy of Sciences of the United States of America·C Shad ThaxtonChad A Mirkin
Feb 27, 2010·Angewandte Chemie·Wenrong YangFilip Braet
Apr 24, 2010·Immunity·Anette-G Ziegler, Gerald T Nepom
Jun 26, 2010·Nature Reviews. Immunology·Agnès LehuenAnne Cooke
Sep 23, 2010·ACS Nano·Fred SchedinAndrea C Ferrari
Nov 22, 2011·Expert Opinion on Medical Diagnostics·Vigneshwaran ManiJames F Rusling
Oct 11, 2012·Current Problems in Pediatric and Adolescent Health Care·Mary Joyce GanMichael J Haller
Jan 24, 2013·Nano Letters·Elton J G Santos, Efthimios Kaxiras
Sep 19, 2014·Nanoscale Research Letters·Nan-Fu ChiuKou-Chen Liu
Jan 13, 2015·Molecular Aspects of Medicine·Michael P MorranMassimo Pietropaolo
Apr 15, 2015·Bioanalysis·Amol V PatilJason J Davis
Jun 17, 2015·Scientific Reports·Gucci Jijuan Gu UrbanMasood Kamali-Moghaddam
Jun 25, 2015·Langmuir : the ACS Journal of Surfaces and Colloids·Marsilea Adela BoothAshton Partridge
Jun 16, 2016·Lancet·Flemming Pociot, Åke Lernmark
Oct 28, 2016·Chemical Communications : Chem Comm·Jinesh NiroulaSadagopan Krishnan
Dec 13, 2017·Chembiochem : a European Journal of Chemical Biology·Min ShenMark W Peczuh

❮ Previous
Next ❯

Citations

Dec 28, 2019·International Journal of Molecular Sciences·Wei XuChung Chiun Liu
Mar 12, 2021·Biosensors & Bioelectronics·K Yugender GoudK Vengatajalabathy Gobi
Feb 23, 2019·Analytical Chemistry·Kristen E WattsJeanne E Pemberton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Biosensor Development & Applications

Biosensor development and applications describe recent progress in biosensor development and their applications in the field of antibiotics and metabolic engineering. Discover the latest research on biosensor development and applications in this feed.

© 2022 Meta ULC. All rights reserved